Understanding Risk Factors and Complications of Immune Thrombocytopenia (ITP)
Published: Aug 04, 2024
Medically reviewed by Angel Kerney | MD, F.A.C.O.G Obstetrics & Gynecology on August 4th, 2024.
Immune thrombocytopenia (ITP) can lead to various complications, and certain factors may increase your risk. This article explores the risk factors and potential complications of ITP.
Contents
Risk Factors for Developing ITP
While the exact cause of ITP is often unknown, certain factors may increase your risk. These include being female, as ITP is more common in women, and being over 60 years old. Some infections, such as HIV, hepatitis C, or Helicobacter pylori, can trigger ITP. Certain autoimmune conditions, like lupus or rheumatoid arthritis, are also associated with a higher risk of developing ITP.
Factors Increasing Bleeding Risk
In ITP, the main concern is an increased risk of bleeding. Certain factors can make bleeding more likely or more severe. These include having a very low platelet count (especially below 10,000 per microliter), being older (particularly over 60), and having a history of significant bleeding. Some medications, like blood thinners or certain pain relievers, can also increase bleeding risk in people with ITP.
Potential Complications
While many people with ITP have mild symptoms, serious complications can occur. The most severe complication is internal bleeding, particularly in the brain, which can be life-threatening. Other potential complications include heavy menstrual bleeding in women, bleeding during pregnancy or childbirth, and an increased risk of infection in people who have their spleen removed as a treatment for ITP.
Frequently Asked Questions
Healthy habits may help, but won't prevent all complications.
Not always; some cases resolve, while others require ongoing management.
Rarely, but regular check-ups can monitor for any changes.
There's no direct link, but some treatments may slightly increase risk.
Key Takeaways
Understanding ITP risk factors and potential complications can help you work with your healthcare team to manage your condition effectively.
For personalized advice on managing ITP risks and complications, reach out to Doctronic today.Related Articles
References
Neunert C, et al. American Society of Hematology 2019 guidelines for immune thrombocytopenia. Blood Adv. 2019;3(23):3829-3866.
Provan D, et al. Updated international consensus report on the investigation and management of primary immune thrombocytopenia. Blood Adv. 2019;3(22):3780-3817.
This article has been reviewed for accuracy by one of the licensed medical doctors working for Doctronic. Always discuss health information with your healthcare provider.